Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation (2013)
- Authors:
- USP affiliated authors: MORALES, ANDRESSA GOIS - IB ; OLIVEIRA, HARLEY FRANCISCO DE - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidades: IB; FMRP
- DOI: 10.1089/cbr.2012.1415
- Subjects: RADIOTERAPIA; MITOSE
- Language: Inglês
- Imprenta:
- Source:
- Título: Cancer Biotherapy and Radiopharmaceuticals
- ISSN: 1084-9785
- Volume/Número/Paginação/Ano: v. 28, n. 7, p. 516-522, 2013
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
PEZUK, Julia Alejandra et al. Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation. Cancer Biotherapy and Radiopharmaceuticals, v. 28, n. 7, p. 516-522, 2013Tradução . . Disponível em: https://doi.org/10.1089/cbr.2012.1415. Acesso em: 04 out. 2024. -
APA
Pezuk, J. A., Brassesco, M. S., Morales, A. G., Oliveira, J. C. de, Oliveira, H. F. de, Scrideli, C. A., & Tone, L. G. (2013). Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation. Cancer Biotherapy and Radiopharmaceuticals, 28( 7), 516-522. doi:10.1089/cbr.2012.1415 -
NLM
Pezuk JA, Brassesco MS, Morales AG, Oliveira JC de, Oliveira HF de, Scrideli CA, Tone LG. Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation [Internet]. Cancer Biotherapy and Radiopharmaceuticals. 2013 ; 28( 7): 516-522.[citado 2024 out. 04 ] Available from: https://doi.org/10.1089/cbr.2012.1415 -
Vancouver
Pezuk JA, Brassesco MS, Morales AG, Oliveira JC de, Oliveira HF de, Scrideli CA, Tone LG. Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation [Internet]. Cancer Biotherapy and Radiopharmaceuticals. 2013 ; 28( 7): 516-522.[citado 2024 out. 04 ] Available from: https://doi.org/10.1089/cbr.2012.1415 - Characterization of LGALS3 (galectin-3) as a player in DNA damage response
- Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells
- In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors
- MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells
- Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro
- Inhibition of NF-'capa'B by dehydroxymethylepoxyquinomicin suppresses invasion and synergistically potentiates temozolomide and 'gama'-radiation cytotoxicity in glioblastoma cells
- Low MIR-196B and high MIR-708 expression are associated with T-cell childhood acute lymphoblastic leukemia
- Silencing of checkpoint mitotic genes inhibits the proliferation and clonogenicity in pediatric glioblastoma cell line
- Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells
- Effects of polo-like kinase 1 inhibition on glioblastoma cell lines
Informações sobre o DOI: 10.1089/cbr.2012.1415 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
